Rolling back the biological clock

In the US alone there are 2.1 million infertile couples. One in five US women now attempts her first pregnancy after age 35 which mean facing infertility issues, the increased risk of a miscarriage, and the fact that it is difficult or impossible for many women over age 35 to have a healthy baby. There are no current therapies that prevent chromosomal abnormalities in a woman’s eggs so she can have a baby with her own eggs. 

Pregmama is a clinical trial stage, female fertility company dedicated to significantly improving the ability of women in their mid-thirties to early forties to conceive and achieve healthy, full-term pregnancies. Dr. Lori Bernstein '80 has invented a first generation therapy called Veriploid™ and a second generation therapy called Eggtivin.™ Both are novel, noninvasive biopharmaceutical therapies for preventing infertility, miscarriages, and birth defects. Pregmama rolls back a woman’s biological clock to produce a young environment for healthy egg development.

To learn more about Pregmama go to